Browsing by Author "Brunet, Salut"

Sort by: Order: Results:

  • Barata, Anna; Rodrigo Martino, Rodrigo; Gich, Ignasi; García-Cadenas, Irene; Abella Monreal, Eugenia; Barba, Pere; Briones, Javier; Brunet, Salut; Esquirol, Albert; García-Pallarols, Francesc; Garrido, Ana; Granell, Miquel; Martinez, Jaume; Mensa, Irene; Novelli, Silvana; Sanchez Gonzalez, Blanca; Valcárcel, David; Sierra, Jordi (Elsevier, 2017)
    Patient and physician agreement on the most significant symptoms is associated with treatment outcomes and satisfaction with care. Thus, we sought to assess patient and physician agreement on patient-reported quality of ...
  • Montoro, Maria Julia; Pomares, Helena; Coll, Rosa; Bernal del Castillo, Teresa; Tormo, Mar; Jiménez, Ana; Brunet, Salut; Casaño, Javier; Oiartzabal, Itziar; Díez-Campelo, María; Ramos, Fernando; Romero, Rafael; Salido-Fiérrez, Eduardo; Pedro Olive, Carme; Bargay, Joan; Muñoz-Novas, Carolina; López, Rocío; Rafel, Montserrat; Valcárcel, David; ERASME study group (Taylor & Francis, 2023)
    Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases without a care standard and show variability in treatment outcomes. This Spanish, observational, prospective study ERASME (CEL-SMD-2012-01) assessed the ...
  • Cabezón, Marta; Bargay, Joan; Xicoy, Blanca; García, Olga; Borràs, Josep M.; Tormo, Mar; Marcé, Sílvia; Pedro Olive, Carme; Valcárcel, David; Jiménez, Maria-José; Guàrdia, Ramón; Valcárcel, David; Jiménez, Maria-José; Palomo, Laura; Brunet, Salut; Vall-llovera, Ferrán; García, Antonio; Feliu, Evarist; Zamora, Lurdes; CETLAM Group (Impact Journal, 2018)
    Myelodysplastic syndromes (MDS) are stem cell disorders caused by various gene abnormalities. We performed targeted deep sequencing in 39 patients with high-risk MDS and secondary acute myeloid leukemia (sAML) at diagnosis ...

Search DSpace


My Account

In collaboration with Compliant to Partaking